← Leaderboards
Masaoki Kawasumi
University Of Washington
$1,159,694
Attributed
$1,159,694
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $403.7K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,159,694 · 1
By mechanism
R01$1,159,694 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Olga Afanasiev$161,744
- Long Fu Xi$3,769,214
- Mary-Claire King$31,748,898
- Nicole Alana Perry Lieberman$485,375
Others in their field
Other Rising Stars on “Driver Mutation”
- Kellie Bickel · Twinstrand Biosciences, Inc.$2,555,383
- Alison F Feder · University Of Washington$2,326,574
- Loretta Erhunmwunsee · Beckman Research Institute/City Of Hope$2,217,862
- Elizabeth Munding · Cantata Bio Llc$1,993,708
- Alexander Federation · Talus Bioscience, Inc.$1,951,023
- Justin Michael Drake · Astrin Biosciences, Inc.$1,931,918
Research focus
Driver MutationDrug CombinationsAutomobile DrivingAcetylationAffinityBinding SitesCarcinogensCdkn2a GeneAffectCell LineBindingCellsCessation Of LifeChromatinChronicCommunitiesCrispr/Cas TechnologyCyclin-Dependent Kinase Inhibitor 2aDemethylationCell Cycle ProteinsDna MethylationDna Methylation InhibitionDna Modification ProcessEnhancers
Grant awards (3)
Targeting epigenetic abnormalities to inhibit cutaneous squamous cell carcinoma$360,281
R01 · FY2025 · CA · contact PI
Targeting epigenetic abnormalities to inhibit cutaneous squamous cell carcinoma$395,669
R01 · FY2023 · CA · contact PI
Targeting epigenetic abnormalities to inhibit cutaneous squamous cell carcinoma$403,744
R01 · FY2022 · CA · contact PI